GLP-1 medications like Ozempic and Wegovy have moved from diabetes clinics into headlines, but the facts are often lost in the hype. Here is a calm, evidence-based explainer of what GLP-1 is, how these prescription drugs actually work, and who they are approved for.
What is GLP-1?
GLP-1 (glucagon-like peptide-1) is a natural hormone made in your gut, released after you eat. You can think of it as one of the body's "I've had enough" signals. Among other jobs, GLP-1 helps your pancreas release insulin when blood sugar rises, slows how fast your stomach empties, and signals fullness to the brain. These are normal, built-in processes — the medications simply borrow this biology.
What are GLP-1 medications, and how do they work?
GLP-1 medications are prescription drugs that mimic the GLP-1 hormone (and, in some cases, a related hormone called GIP). By acting on the same receptors, they:
- Slow stomach emptying, so you feel full longer after meals.
- Curb appetite and reduce food-related cravings, so most people eat less without forcing it.
- Improve blood sugar by helping the body release insulin more effectively when it is needed.
Because appetite and blood sugar are regulated together, the same drug can help with both diabetes control and weight.
The main GLP-1 medications
The two active ingredients you will hear most about are semaglutide and tirzepatide. They are sold under different brand names depending on what they are approved to treat, and several have additional approved uses beyond the headline ones below.
| Active ingredient | Brand names | Main approved use(s) |
|---|---|---|
| Semaglutide | Ozempic | Type 2 diabetes; also to lower certain cardiovascular and kidney risks in some adults with type 2 diabetes |
| Semaglutide | Wegovy | Chronic weight management; also to lower cardiovascular risk in some adults with established heart disease who are overweight or have obesity |
| Tirzepatide (dual GLP-1/GIP agonist) | Mounjaro | Type 2 diabetes |
| Tirzepatide | Zepbound | Chronic weight management |
Tirzepatide is described as a dual agonist because it acts on two gut-hormone receptors (GLP-1 and GIP) rather than one — a different mechanism from single-target semaglutide.
Who are GLP-1 medications approved for?
These are prescription medicines, not a cosmetic quick fix. In general, they are approved for:
- Type 2 diabetes — to help manage blood sugar, alongside diet and activity (and, for some products, to lower certain heart or kidney risks).
- Chronic weight management — typically for adults above certain body mass index (BMI) thresholds, usually when there is also a weight-related health condition such as high blood pressure, sleep apnea or type 2 diabetes.
Whether any of this applies to you is a clinical decision. A clinician weighs your full medical history, other medications, and goals — not a number on a scale alone. This article is general information, not medical advice or a recommendation to start any drug.
Does GLP-1 help with weight loss?
In clinical trials, GLP-1 and dual-agonist medications produced significant average weight loss compared with placebo when combined with lifestyle changes. But averages hide a wide range: some people lose a lot, others much less, and a minority do not respond well. Results vary, and the trial conditions (close monitoring, support, dose adjustments) are not the same as everyday life.
Two honest caveats matter most:
- This is usually long-term treatment. The medication manages appetite and blood sugar while you take it — it does not "cure" the underlying biology.
- Weight often returns after stopping. Studies show much of the lost weight tends to come back when the drug is discontinued, which is why lifestyle still matters — quality of food, movement, sleep and stress all keep doing their work.
If you are in midlife, hormonal shifts add another layer. See menopause weight gain and menopause belly fat for how falling estrogen changes where the body stores fat, and metabolism and age for why your resting metabolism stays fairly steady from about 20 to 60 — it does not "crash" in your 30s or 40s the way the myth suggests.
How does Ozempic work versus Wegovy?
This is a common point of confusion, so to be clear: Ozempic and Wegovy are the same active ingredient (semaglutide). The difference is what each brand is approved and dosed for — Ozempic primarily for type 2 diabetes, Wegovy for chronic weight management. They are not interchangeable products you choose between casually; the right one, if any, is part of a prescribing decision. We do not give dosing here on purpose.
Side effects and safety
No effective medication is free of risk. We cover this fully in Ozempic and Wegovy side effects, but in brief:
- Common: nausea, vomiting, diarrhea or constipation, especially early on.
- Less common but serious: pancreatitis, gallbladder problems, kidney issues (often linked to dehydration from vomiting), and low blood sugar.
- Boxed warning: these drugs carry a warning based on thyroid C-cell tumors seen in rodents. Whether this applies to humans is not established, so the related contraindication below is a precautionary, regulatory safeguard rather than proof of harm in people.
On low blood sugar (hypoglycemia): on their own, GLP-1 medications carry a relatively low risk, but that risk rises when they are combined with insulin or sulfonylureas. It can be serious, and a clinician may need to lower the dose of those other diabetes medicines — not something to adjust on your own.
Rapid facial fat loss — popularly called "Ozempic face" — is an ordinary cosmetic effect of losing weight quickly, not a unique drug toxicity.
Key cautions and contraindications (not a complete list)
GLP-1 medications are generally not appropriate for people with a personal or family history of medullary thyroid carcinoma or MEN2, and they are not recommended in pregnancy or breastfeeding. Clinicians also weigh added caution with a history of pancreatitis or gallbladder disease, significant gastrointestinal conditions such as gastroparesis, and known hypersensitivity to the drug. They are not used for type 1 diabetes or diabetic ketoacidosis. This is only a partial list — solely a clinician reviewing your full history can judge suitability.
What about "natural" alternatives and online sources?
Supplements marketed as "nature's Ozempic," such as berberine, are not equivalent to GLP-1 drugs. The evidence for berberine is modest and mostly about blood sugar and lipids, and it carries real interaction and safety caveats. Be cautious, too, of unverified "compounded" or grey-market online sources, and never use a prescription written for someone else — purity, dosing and safety cannot be assured.
The bigger weight picture
Weight is multifactorial, not a willpower failure. Thyroid function (thyroid and weight), stress hormones (cortisol and weight), and insulin resistance in conditions like PCOS all play a role. GLP-1 medications are one tool that may suit some people — alongside, never instead of, addressing the whole hormonal and lifestyle picture.
When to see a clinician
Talk to a doctor or qualified clinician — rather than self-prescribing — if you are considering a GLP-1 medication, are curious whether you qualify, or are weighing it against other options. Seek care promptly if you experience any of the following while taking one:
- Severe or persistent abdominal pain (especially radiating to the back), which can signal pancreatitis.
- Signs of gallbladder trouble — pain in the upper right abdomen, fever, or yellowing of the skin or eyes.
- Symptoms of dehydration or kidney strain from ongoing vomiting or diarrhea.
- A lump or swelling in the neck, trouble swallowing, or hoarseness.
- Signs of low blood sugar — shakiness, sweating, confusion — particularly if you take insulin or other diabetes medicines.
And always tell your clinician your full history, including any thyroid cancer, MEN2, pancreatitis, or pregnancy plans, before starting. The goal is a safe, informed decision made together — not a trend followed alone.
